Literature DB >> 7650107

Episodic and semantic memory in Alzheimer's disease and progressive supranuclear palsy: a comparative study.

P R van der Hurk1, J R Hodges.   

Abstract

We compared 13 patients with dementia of the Alzheimer's type (DAT) and 9 progressive supranuclear palsy (PSP) patients, matched by age, sex, education, and the overall level of cognitive deterioration, measured by using the Dementia Rating Scale, and 12 normal controls. The results of this study confirm that the pattern of cognitive deterioration of PSP patients differs from that of DAT patients. While episodic memory is severely affected early in the course of DAT, it appears to be relatively spared in PSP. In contrast to previous suggestions, we found no evidence for differentially rapid forgetting in DAT, although we did confirm relatively preserved recognition memory in PSP. We had predicted that the performance of the DAT group on tests of semantic memory (the Boston Naming Test, the ADA Synonym Judgement Test, and the Pyramids and Palm Trees Test) would be worse than that of the PSP group. However, there was, in fact, no difference on any of these measures, except that the PSP patients showed a significantly greater deficit on the Synonym Judgement Test. We suggest that the underlying cause of the semantic memory impairment might, however, be different in the two pathologies.

Entities:  

Mesh:

Year:  1995        PMID: 7650107     DOI: 10.1080/01688639508405137

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  10 in total

Review 1.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

2.  Progressive supranuclear palsy presenting with dynamic aphasia.

Authors:  T Esmonde; E Giles; J Xuereb; J Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

3.  Object perception impairments predict instrumental activities of daily living dependence in Alzheimer's disease.

Authors:  Angela L Jefferson; Lamia P Barakat; Tania Giovannetti; Robert H Paul; Guila Glosser
Journal:  J Clin Exp Neuropsychol       Date:  2006-08       Impact factor: 2.475

4.  Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy.

Authors:  T Esmonde; E Giles; M Gibson; J R Hodges
Journal:  J Neurol       Date:  1996-09       Impact factor: 4.849

5.  Language boosting by transcranial stimulation in progressive supranuclear palsy.

Authors:  Antoni Valero-Cabré; Clara Sanches; Juliette Godard; Oriane Fracchia; Bruno Dubois; Richard Levy; Dennis Q Truong; Marom Bikson; Marc Teichmann
Journal:  Neurology       Date:  2019-07-03       Impact factor: 9.910

6.  Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.

Authors:  Adam Gerstenecker; Benjamin Mast; Kevin Duff; Tanis J Ferman; Irene Litvan
Journal:  Arch Clin Neuropsychol       Date:  2012-11-04       Impact factor: 2.813

7.  Association between semantic dementia and progressive supranuclear palsy.

Authors:  Julie S Snowden; Christopher Kobylecki; Matthew Jones; Jennifer C Thompson; Anna M Richardson; David M A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-04-16       Impact factor: 10.154

8.  Assessment of neuropsychological function in brain tumor treatment: a comparison of traditional neuropsychological assessment with app-based cognitive screening.

Authors:  Rafael Romero-Garcia; Mallory Owen; Alexa McDonald; Emma Woodberry; Moataz Assem; Pedro Coelho; Rob C Morris; Stephen J Price; Tom Santarius; John Suckling; Tom Manly; Yaara Erez; Michael G Hart
Journal:  Acta Neurochir (Wien)       Date:  2022-03-01       Impact factor: 2.816

Review 9.  Language impairment in progressive supranuclear palsy and corticobasal syndrome.

Authors:  Katie A Peterson; Karalyn Patterson; James B Rowe
Journal:  J Neurol       Date:  2019-07-18       Impact factor: 4.849

10.  Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study.

Authors:  Pearl Behl; Jodi D Edwards; Alexander Kiss; Krista L Lanctot; David L Streiner; Sandra E Black; Donald T Stuss
Journal:  Alzheimers Res Ther       Date:  2014-08-18       Impact factor: 6.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.